States vs. Federal Govt. in the Fight for Legalization
Even with California, the sixth biggest economy in the world, legalizing pot, incongruities in state and federal law hinder growth in the marijuana market.
That’s according to Paul Armentano, Deputy Director of the National Organization for the Reform of Marijuana Laws (NORML).
“Californians, like most Americans, believe that it’s preferable to have the commercial marijuana market governed by licensed businesses, rather than by cartels and drug dealers,” Armentano said.
“But unfortunately these businesses, even when they are state compliant and locally compliant, largely cannot act in a transparent manner, because they do not have access to banking. They can’t run credit cards, and we see little accountability or transparency because of this conflict with the federal government.”
But there might be some progress. Legalizing marijuana on a federal level has gained bipartisan support in Congress, with Representatives Tom Garrett (R-VA) and Tulsi Gabbard (D-HI) introducing a bill last March calling for an end to marijuana prohibition on the federal level.
The “Ending Federal Marijuana Prohibition Act of 2017” would put legislative power in the hands of states and remove cannabis as a Schedule I drug. Knowingly taking marijuana to a state where it’s prohibited, though, would still be subject to criminal penalties.
For full interview [click here](https://cheddar.com/videos/weed-across-america-federal-vs-state-laws).
A new federal rule would make it easier for companies to use drones over longer distances out of sight of the operator without having to go through a cumbersome waiver process.
President Donald Trump has signed the GENIUS Act into law, setting new regulations for stablecoins, a type of cryptocurrency tied to assets like the U.S. dollar.
A top Federal Reserve official said late Thursday that the central bank should cut its key interest rate later this month, carving out a different view than that of Chair Jerome Powell
Stocks fell on Wall Street as the Trump administration stepped up pressure on trading partners to make deals before punishing tariffs imposed by the U.S. take effect.
A stark disagreement over regulating AI in Republicans’ tax cut and spending bill is the latest tension among conservatives about whether to let states continue to put guardrails on emerging technologies or minimize such interference.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
At some 940-pages, the legislation is a sprawling collection of tax breaks, spending cuts and other Republican priorities, including new money for national defense and deportations.
